Home / NIH / In-Vitro Diagnostic Substance Manufacturing / Notice

Reagents and consumables for Roche immunostainers

Updated

Solicitation from the National Institutes of Health, for work in Bethesda, Maryland. Due Nov 18, 2026, 8:00 AM (UTC-5), 7 days left.

Be among the first to see new In-Vitro Diagnostic Substance Manufacturing contracts
Only new notices that match, once a day.
Solicitation number75N98027Q00026
AgencyNational Institutes of Health
OfficeNational Institutes of Health Olao
Notice typeSolicitation
Set-asideNone
Trade (NAICS)In-Vitro Diagnostic Substance Manufacturing (325413)
Product or service code6640
Place of performanceBethesda, Maryland
PostedNov 10, 2026
Response deadlineNov 18, 2026, 8:00 AM (UTC-5) (7 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Bid documents (3)

Paid members download every document from this page, or buy this bid alone.

Federal prevailing wage rates for this place: Maryland Davis-Bacon and SCA wage determinations.

Description

Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 325413, a business counts as small if it has no more than 1,250 employees (SBA size standard). This notice is not set aside, but the size decides your small business status on it. SBA table, current as of Oct 15, 2026.

Notice history

Companies that win this kind of work

Federal contractors paid for in-vitro diagnostic substance manufacturing work, who also hold NIH contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The National Institutes of Health awarded $5.9 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.

In-Vitro Diagnostic Substance Manufacturing contracts right now

There are 20 open government contract opportunities in this trade (NAICS 325413), 10 posted in the last 7 days; 55% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Defense Health Agency (DHA) and National Institutes of Health. Most of the work with a stated place is in Maryland, Texas and Arizona. A notice in this trade gives a median of 15 days from posting to deadline; this one gives 8 days.

All open in-vitro diagnostic substance manufacturing contracts

Coming up in this trade

Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.

New contract needed for Enrichment Broth used within all three labs. We want a base year plus 4 option years.
Food Safety and Inspection Service
Acquisition Planning · Award FY 2027 · $500K - $999K · Firm Fixed Price

Recent awards in this trade

From the award notices agencies publish.

Similar open in-vitro diagnostic substance manufacturing bids

Flow Cytometry Reagents
Department of Veterans Affairs
Due Nov 12, 2026, 12:00 PM (UTC-5) · 1 day left
Sources Sought · Baltimore, MD · Posted Nov 2, 2026
Redacted Justification and Approval for Other Than Full and Open Competition Sequencing System for HIV-1 Genotype Testing
Defense Health Agency (DHA)
Justification · Silver Spring, MD · Posted Oct 1, 2026
Abbott Architect i1000 Reagents
Department of Veterans Affairs
Due Nov 13, 2026, 1:00 AM (UTC-8) · 2 days left
Solicitation · Small business · Tucson, AZ · Posted Nov 10, 2026
VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement
Department of Veterans Affairs
Due Nov 18, 2026, 5:00 PM (UTC-8) · 7 days left
Solicitation · Boise, ID · Posted Nov 10, 2026
6550 Reagents Consumables Microbiology Testing Boise VAMC
Department of Veterans Affairs
Due Nov 27, 2026, 5:00 PM (UTC-8) · 16 days left
Sources Sought · ID · Posted Nov 9, 2026
Optilite analyzer reagents
Department of Veterans Affairs
Solicitation · Posted Nov 9, 2026